The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 11, 2022
Filed:
Jun. 22, 2016
Applicant:
Cellis Sp. Z O.o. [ltd.], Warsaw, PL;
Inventors:
Magdalena Krol, Warsaw, PL;
Irene Benni, Rome, IT;
Paola Baiocco, Rome, IT;
Tomasz Rygiel, Warsaw, PL;
Alberto Boffi, Rome, IT;
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/15 (2015.01); A61K 51/12 (2006.01); A61K 47/68 (2017.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61K 35/17 (2015.01); A61K 45/06 (2006.01); A61K 49/00 (2006.01); A61K 49/18 (2006.01); A61K 51/04 (2006.01); C12N 5/0783 (2010.01); C12N 5/0787 (2010.01); C12N 5/0786 (2010.01);
U.S. Cl.
CPC ...
A61K 51/1203 (2013.01); A61K 35/15 (2013.01); A61K 35/17 (2013.01); A61K 45/06 (2013.01); A61K 47/64 (2017.08); A61K 47/644 (2017.08); A61K 47/6445 (2017.08); A61K 47/6811 (2017.08); A61K 47/6901 (2017.08); A61K 49/0056 (2013.01); A61K 49/1896 (2013.01); A61K 51/0497 (2013.01); C12N 5/0636 (2013.01); C12N 5/0642 (2013.01); C12N 5/0645 (2013.01); C12N 5/0646 (2013.01); C12N 2501/15 (2013.01); C12N 2501/21 (2013.01); C12N 2501/231 (2013.01); C12N 2501/2304 (2013.01); C12N 2501/2313 (2013.01); C12N 2501/24 (2013.01); C12N 2501/25 (2013.01); C12N 2501/90 (2013.01); C12N 2501/999 (2013.01);
Abstract
The present invention relates to an isolated cellular targeted delivery system comprising a CD45leukocyte cell comprising within said cell a complex of one or more iron binding proteins and an active ingredient as well as methods for producing such isolated cellular targeted delivery system and uses of such system for therapy, in particular for therapy of cancer.